Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience

被引:0
|
作者
Lupone, G. [1 ]
Antonino, A. [2 ]
Rosato, A. [3 ]
Zenone, P. [1 ]
Iervolino, E. M. [1 ]
Grillo, M. [1 ]
De Palma, M. [1 ]
机构
[1] Antonio Cardarelli Hosp, Endocrine & Gen Surg Unit, Naples, Italy
[2] Federico II Univ Napoli, Antonio Cardarelli Hosp, Dept Gen Surg Geriatr Oncol & Adv Technol, Naples, Italy
[3] Federico II Univ Napoli, Antonio Cardarelli Hosp, Dept Gen & Endocrine Surg, Naples, Italy
来源
GIORNALE DI CHIRURGIA | 2012年 / 33卷 / 11-12期
关键词
Medullary thyroid carcinoma; Total thyroidectomy; Neck dissection;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Medullary thyroid carcinoma (MTC) is a rare disease which accounts for approximately 5-9% of all thyroid cancers and originates from the calcitonin-secerning parafollicular C cells. MTC can be divided into two subgroups: sporadic (75%) or inherited (25%). The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies. Objectives. The purpose of the study is to review our single institution's experience with MTC since 1998 and to evaluate surgical strategy, patterns of lymph node metastases and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent sporadic medullary thyroid carcinoma. Methods. A retrospective review of 26 patients treated for MTC at the "Antonio Cardarelli" Hospital referral center, in Naples, between 1998 and 2012. There were 18 female and 8 male patients, median age at presentation was 55 years, and median follow-up for survivors was 5 years. Total thyroidectomy was performed in all 26 patients; central compartment (CC) node dissection ( level VI) in 12 (46%) patients; central plus lateral compartment (LC) node dissection (levels II, III, and IV) in 7 (27%) patients. 4 patients (15%) underwent reoperation for loco-regional recurrent/persistent MTC. Results. After a median post-surgical follow-up of 5 years (range 110 years), 63 % of patients were living disease-free, 15% were living with disease and/or persistently elevated calcitonin levels after surgery, 11% were deceased due to MTC and 11 % were lost to follow-up. Conclusions. We agree with most authors advocating for a total thyroidectomy and prophylactic central neck dissection in the setting of clinically detected MTC. Lateral neck dissection may be best reserved for patients with positive preoperative imaging. Nevertheless MTC has a high rate of lymph node metastases that are sub optimally detected preoperatively in the central compartment by neck ultrasound or intra-operatively by the surgeon, and reoperation is associated with a higher rate of surgical complications. In our limited experience, patients with thyroid confined nodular pathology, without nodal disease and unknown preoperative diagnosis of MTC, underwent only total thyroidectomy with a good prognosis.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 50 条
  • [31] Our experience in complex treatment of thyroid carcinoma
    Atanasov, A
    Kalinova, K
    Ratshcov, I
    Valtshev, D
    BRITISH JOURNAL OF SURGERY, 1998, 85 : 133 - 133
  • [32] Invited Commentary: "Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience."
    Commander, Sarah Jane
    Fitzgerald, Tamara N.
    WORLD JOURNAL OF SURGERY, 2021, 45 (08) : 2480 - 2481
  • [33] Invited Commentary: “Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience.”
    Sarah Jane Commander
    Tamara N. Fitzgerald
    World Journal of Surgery, 2021, 45 : 2480 - 2481
  • [34] NEW OPERATIVE STRATEGY IN THE TREATMENT OF METASTASIZING MEDULLARY CARCINOMA OF THE THYROID
    BUHR, HJ
    LEHNERT, T
    RAUE, F
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1990, 16 (04): : 366 - 369
  • [35] Our experience on surgical treatment of papillary thyroid microcarcinoma
    Ciuffreda, L.
    De Martino, D.
    Bonfitto, N.
    Scaramuzzi, R.
    GIORNALE DI CHIRURGIA, 2011, 32 (1-2): : 41 - 44
  • [36] Outcome of Treatment for Medullary Thyroid Carcinoma—a Single Centre Experience
    Cherian A.J.
    Ramakant P.
    Pai R.
    Manipadam M.T.
    Elanthenral S.
    Chandramohan A.
    Hephzibah J.
    Mathew D.
    Naik D.
    Paul T.V.
    Rajaratnam S.
    Thomas N.
    Paul M.J.
    Abraham D.T.
    Indian Journal of Surgical Oncology, 2018, 9 (1) : 52 - 58
  • [37] SURGICAL IMPLICATIONS OF MEDULLARY CARCINOMA OF THYROID
    JOHNSTON, ID
    WATSON, AJ
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1970, 63 (06): : 612 - &
  • [38] WHEN IS A THYROID-NODULE A SPORADIC MEDULLARY CARCINOMA
    DUNN, JT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04): : 824 - 825
  • [39] Sporadic Medullary Thyroid Carcinoma with Paraneoplastic Cushing Syndrome
    Pivovarova, Aleksandra I.
    Patrick, Stephanie
    Reddy, Punuru J.
    CASE REPORTS IN ENDOCRINOLOGY, 2019, 2019
  • [40] MEDULLARY CARCINOMA OF THYROID - SURGICAL IMPLICATIONS
    BLOCK, MA
    MILLER, JM
    HORN, RC
    ARCHIVES OF SURGERY, 1968, 96 (04) : 521 - &